Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Point-of-Care Diagnostics, Global Health & Biosensors 2019

Rustem Ismagilov's Biography



Rustem Ismagilov, Ethel Wilson Bowles and Robert Bowles Professor of Chemistry and Chemical Engineering, California Institute of Technology

Rustem Ismagilov was born in Ufa, Russia. He graduated from the Higher Chemical College of the Russian Academy of Sciences, Moscow (1994), before coming to the US to complete his PhD in physical organic chemistry at the University of Wisconsin-Madison (1998). He conducted his postdoctoral work at Harvard University and began his independent research career in 2001, as an Assistant Professor at the University of Chicago, Department of Chemistry. In 2011, he joined the Division of Chemistry and Chemical Engineering at the California Institute of Technology and in 2013 he became the Ethel Wilson Bowles and Robert Bowles Professor of Chemistry and Chemical Engineering. He also serves as the director of the Jacobs Institute for Molecular Engineering for Medicine at Caltech. His lab has developed new approaches to studies of complex chemical and biological networks, and pioneered microfluidic technologies (including droplet-based microfluidics and SlipChip microfluidics) and diagnostic technologies. Current work in the lab includes studies of the impact of the gut microbiome on its host, and development of technologies for rapid diagnosis of antimicrobial susceptibility of pathogens. The work by his research group has been recognized by a number of awards, including the Cozzarelli Prize from the National Academy of Sciences (2007), the NIH Director’s Pioneer Award (2007) and the ACS Award in Pure Chemistry (2008). He was elected a fellow of the American Academy for the Advancement of Science (2010), and was awarded a Burroughs Wellcome Fund fellowship in Innovation in Regulatory Science Award (IRSA) (2015) and a Kenneth Rainin Innovator Award (2018).

Rustem Ismagilov Image

Rapid Diagnostics of Antibiotic Resistance

Monday, 7 October 2019 at 16:15

Add to Calendar ▼2019-10-07 16:15:002019-10-07 17:15:00Europe/LondonRapid Diagnostics of Antibiotic ResistancePoint-of-Care Diagnostics, Global Health and Biosensors 2019 in Coronado Island, CaliforniaCoronado Island, CaliforniaSELECTBIOenquiries@selectbiosciences.com

Rapid antibiotic susceptibility testing (AST) is critical for determining appropriate treatments and for enabling global antibiotic stewardship.  Phenotypic AST is the gold standard, but these tests are unacceptably slow, requiring pre-culture steps.  Genotypic AST methods are not sufficiently general to replace the gold standard (especially in Gram-negative organisms).  Our lab uses microfluidic digital single-molecule counting of pathogen-specific RNA and DNA to perform phenotypic AST directly from clinical samples in as fast as 30 min. Further, we have demonstrated refinements of this approach that can enable rapid AST in high-priority organisms such as Neisseria gonorrhoeae and Carbapenem-resistant Enterobacteriaceae (CRE).


Add to Calendar ▼2019-10-07 00:00:002019-10-09 00:00:00Europe/LondonPoint-of-Care Diagnostics, Global Health and Biosensors 2019Point-of-Care Diagnostics, Global Health and Biosensors 2019 in Coronado Island, CaliforniaCoronado Island, CaliforniaSELECTBIOenquiries@selectbiosciences.com